In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1857 News Items found
Looking through a microscope at a tissue sample
MSK Research Highlights, December 29, 2023

New MSK research developed CAR T cells that target two acute myeloid leukemia-specific antigens; shed new light on a genetic element called LINE-1, opening the door to new treatments; identified a key regulator of blood stem cell fate; and found an immunotherapy technique using antibodies that target CD47 shows promise in mice.
Christine Mayr
Location, Location, Location: The Hidden Power of Intracellular Neighborhoods

New findings provide details about the hidden organization of the cytoplasm, showing it makes a big difference where in that cellular broth that messenger RNA (mRNA) get translated into proteins. The findings hold promise for increasing or altering the production of proteins in mRNA vaccines and therapies.
MSK radiation oncologist and neuroblastoma expert Suzanne Wolden with a patient
In the Clinic
Reduced Radiation for Neuroblastoma Could Lessen Children’s Side Effects Later

Learn how MSK doctors are exploring the use of less radiation in neuroblastoma treatment so children can avoid side effects.
a researcher holds a sign reading "Proud to be an MSK scientist"
Top Cancer Research Advances at MSK in 2023

Researchers at MSK pioneered many discoveries in 2023. Read about some of the most important findings.
Dr. Christopher Klebanoff
Feature
A New Type of Immunotherapy: MSK’s Christopher Klebanoff Is Fighting Cancer Cells From the Inside Out With T Cell Receptor (TCR) Therapy

Learn how MSK physician-scientist Christopher Klebanoff is working to bring immunotherapy to more patients, especially those with solid tumors.
MSK endometrial cancer specialists are seen: gynecological surgeon Carol Brown, MD; Carol Aghajanian, MD, Chief of the Gynecological Medical Oncology Service; medical oncologist Ying Liu, MD, MPH; and molecular geneticist Britta Weigelt, PhD.
Endometrial Cancer: New Insights Into a Deadly Disparity

Learn about new insights into endometrial cancer discovered by MSK experts, including why the growing rates of this cancer are even more dangerous for Black women.
Alicia Kalogeropoulos with her husband, Alex, at the beach.
Feature
Top Cancer Treatment Advances at MSK in 2023

Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in many types of cancer treatment for patients in 2023. Read about some of the most important developments over the past year.
Patient receiving stereotactic body radiation therapy at Memorial Sloan Kettering Cancer Center.
Ablative Radiotherapy Controls Resistant Non-Small Cell Lung Cancer in Clinical Trial

Learn how highly focused, intense radiation can stop lung cancer from growing after it has spread to a small number of sites.
Dr. Lorenzo Falchi
In the Clinic
Blood Test To Identify Which Large B Cell Lymphoma Patients Are Candidates for Glofitamab Shows Promise in Clinical Trial

Learn about results from a clinical trial that found blood tests can help predict which patients with large B cell lymphoma are likely to benefit from the targeted therapy glofitamab (Columvi).
Anne and Robert Schmiedel
In the Clinic
New Treatment Results for Follicular Lymphoma Clinical Trial Presented at ASH 2023

A clinical trial of the targeted therapy mosunetuzumab (Lunsumio) has found this drug may help patients with follicular lymphoma avoid chemotherapy. Learn more about how it benefited patients who had not yet received other treatments for their lymphoma.